![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Takeda Gmbh Konstanz De, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Pantoprazole sodium sesquihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-246 - Rev 05
This Chemical Type CEP, issued on March 11, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2296 associated with this CEP further emphasizes